In addition to further investigations of the three miRNAs' role in MMP-9 regulation, neurological deterioration and HT development, future studies should perform longitudinal analysis of a large, preferably multi-center population to develop a complete, time-specific miRNA expression profile for HT prediction in cardioembolic stroke patients. Here, MMP9 is linked to hematocrit.